On March 18, 2020, Emergent BioSolutions announced a manufacturing partnership with Vaxart to develop the vaccine.
Tarehe 18 Machi 2020, Emergent BioSolutions ilitangaza ushirikiano wa utengenezaji na Vaxart ili kukuza chanjo hiyo.